title: [Chemotherapy in cancer of the lung].
abstract: In the early stages of non-small cell lung cancer, postoperative administration of a combination of vinorelbine and cisplatin is of proven benefit. Chemotherapy is applied pre-operatively in the case of locally advanced stages, and in parallel with radiotherapy in the case of inoperable tumors. For advanced and metastatic stages of non-small cell lung cancer, combination therapy or monotherapy with antibodies may be considered. These are directed against tumor-specific structures (targeted therapy). In the case of early-stage non-small cell lung cancer the classical combinations, but also new substances are employed.
authors.affiliation: Robert-Koch-Klinik, Klinikum St. Georg, Leipzig. sylvia.guetz@sanktgeorg.de
authors.forename: S
authors.initials: S
authors.lastname: Gütz
mesh_terms: D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use*; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy* / Q000401:mortality / Q000473:pathology / Q000601:surgery; D018288:Carcinoma, Small Cell / Q000188:drug therapy* / Q000401:mortality / Q000473:pathology / Q000601:surgery; D017024:Chemotherapy, Adjuvant; D003131:Combined Modality Therapy; D016503:Drug Delivery Systems; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000401:mortality / Q000473:pathology / Q000601:surgery; D009367:Neoplasm Staging; D016019:Survival Analysis
chemical_list: D000970:Antineoplastic Agents